Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.52
-0.05 (-3.07%)
At close: May 09, 2025, 2:51 PM
1.55
1.97%
After-hours: May 09, 2025, 04:59 PM EDT
-3.07% (1D)
| Bid | 1.5 |
| Market Cap | 15.46M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -17.5M |
| EPS (ttm) | -1.72 |
| PE Ratio (ttm) | -0.88 |
| Forward PE | -0.61 |
| Analyst | Buy |
| Ask | 1.64 |
| Volume | 2,067 |
| Avg. Volume (20D) | 22,160 |
| Open | 1.65 |
| Previous Close | 1.57 |
| Day's Range | 1.44 - 1.65 |
| 52-Week Range | 1.12 - 3.26 |
| Beta | 2.13 |
About COCP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COCP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COCP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+6.64%
Cocrystal Pharma shares are trading higher after t...
Unlock content with
Pro Subscription
4 months ago
-37.85%
Cocrystal Pharma shares are trading lower after the company announced disappointing low infectivity rates for the Oral PB2 inhibitor CC-42344 and will extend its Phase 2a influenza challenge study.
